South Korea Hormonal Contraceptive Market Size, Share, and COVID-19 Impact Analysis, By Method (Pill and IUD), By Hormone (Combination Hormonal Contraceptives and Progestin-only), and South Korea Hormonal Contraceptive Market Insights, Industry Trend, Forecasts to 2035

South Korea Hormonal Contraceptive Market Insights Forecasts to 2035

• The South Korea Hormonal Contraceptive Market Size Was Estimated at USD 115.8 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.92% from 2025 to 2035
• The South Korea Hormonal Contraceptive Market Size is Expected to Reach USD 196.39 Million by 2035

According to a research report published by Spherical Insights and Consulting, The South Korea Hormonal Contraceptive Market Size is anticipated to reach USD 196.39 Million by 2035, growing at a CAGR of 4.92% from 2025 to 2035. The factors driving the industry's growth are rising major-player investments in the research and development of new contraceptive devices, growing awareness of hormonal contraceptive methods in emerging economies, and supportive government initiatives to expand access to contraceptive products. Increased knowledge of the different ways to prevent pregnancy is anticipated to stimulate industry expansion.

Market Overview

The hormonal contraceptive market involves the development, production, and distribution of contraceptive methods that use synthetic hormones estrogen, progestin, or both to prevent pregnancy. These include pills, patches, injections, implants, and intrauterine devices (IUDs). High effectiveness, regulation of menstrual cycles, reduced risk of certain cancers, and treatment for hormonal imbalances. The rising awareness of family planning, increased female workforce participation, and growing demand for long-acting reversible contraceptives. Technological advancements and greater access through telemedicine also support market growth.

Report Coverage

This research report categorizes the market for South Korea hormonal contraceptive market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea hormonal contraceptive market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea hormonal contraceptive market.

Driving Factors        

The hormonal contraceptive market is driven by rising awareness of reproductive health, increasing demand for family planning, and a growing number of women in the workforce seeking reliable birth control methods. Technological advancements in drug delivery systems, such as implants and patches, improve convenience and compliance. Government-supported healthcare initiatives and access to contraception through public health programs further fuel growth. Additionally, shifting societal attitudes toward planned parenthood and the treatment of hormonal disorders enhance the market expansion.

Restraining Factors

Common side effects such as weight gain, headaches, and mood changes can deter users, while long-term health concerns and misinformation reduce acceptance. Cultural and religious beliefs in some regions contribute to stigma around contraceptive use, especially among unmarried women. Limited access in rural or low-income areas, combined with the cost of ongoing treatment, also restricts usage. Inadequate sexual education fosters misconceptions, further slowing the adoption of hormonal methods.

Market Segmentation

The South Korea Hormonal Contraceptive Market share is classified into method and hormone.

• The pill segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea hormonal contraceptive market is segmented by method into pill and IUD. Among these, the pill segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Simple and quick administration, readily available goods, increased knowledge of tablets in comparison to long-acting reversible devices, and higher efficiency of roughly 99% in timely intake are all factors contributing to the segment's rise. It is anticipated that increasing penetration in developing nations will support category expansion.

• The combination hormonal contraceptives segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea hormonal contraceptive market is segmented by method into combination hormonal contraceptives and progestin-only. Among these, the combination hormonal contraceptives segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. It prevents pregnancy through two distinct processes, which increase success rates, the segment's growth can be ascribed to the decreased risk of pregnancy. Compared to progestin-only pills, these contraceptives are linked to a decreased risk of acne.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea hormonal contraceptive market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Hanmi Pharm Co., Ltd.
• Chong Kun Dang Pharmaceutical Corp.
• Yuhan Corporation
• Daewoong Pharmaceutical Co., Ltd.
• Bukwang Pharmaceutical Co., Ltd.
• Pfizer Pharmaceuticals Korea Ltd.
• Bayer Korea Ltd.
• ILDONG Pharmaceutical Co., Ltd.
• Mylan Laboratories Korea Ltd.
• Church & Dwight Co., Inc.
• CooperSurgical, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea hormonal contraceptive market based on the below-mentioned segments:

South Korea Hormonal Contraceptive Market, By Method

• Pill
• IUD

South Korea Hormonal Contraceptive Market, By Method

• Combination Hormonal Contraceptives
• Progestin-only